Home Overview Press Room Blog Publications For Students about us
Search

Personal genomics : Displaying 200-219 of 737


Counsyl Gets Funding for New Genetic Tests[Quotes CGS's Marcy Darnovsky]by Stephanie M. LeeSan Francisco ChronicleMay 8th, 2014The San Francisco startup, Counsyl, has just released a test that screens men and women for their inherited risks of breast, ovarian, prostate and pancreatic cancers.
Direct-to-Consumer Genetic Testing: a Case of Potential Harmby Nancy FlieslerVectorMay 5th, 2014A case report in Clinical Pharmacology & Therapeutics provides what may be the first evidence of potential harm caused by errors in test interpretation by a DTC company.
Consumer Gene Tests Face Uncertain Futureby Andrea KissackKQEDMay 5th, 2014Direct-to-consumer genetic testing took a blow last year when the government cracked down on Mountain View company 23andMe. Now, the company is working to be able to offer health information again.
Parents and Children Deserve Genetic Privacyby Twila BraseUS News & World ReportMay 1st, 2014Newborn screening has many health benefits. But ownership of infant samples and the DNA they carry must not be transferred from newborns to the state.
DNA Day Hypeby Nathaniel ComfortGenotopiaApril 25th, 2014To celebrate DNA Day, the genetic testing company 23andMe posted a DNA Day infographic that is a marvelous inadvertent evidence of genetic oversell.
Is Illumina’s $1,000 Genome a Reality? Not for Clinical Laboratory Purposes, Asserts an In Vitro Diagnostics Expert by Joseph BurnsDark DailyApril 21st, 2014Gene sequencing for clinical purposes requires more resources, including the costs of experts to interpret data to help pathologists and physicians involved in the case.
How I Hacked My Best Friend’s Genome — And Could Hack Yours Tooby Sharon MoalemMediumApril 15th, 2014You just never know when someone may want to hack your genome.
Genetic Information: The Voices From The Fault Linesby Jessica CussinsBiopolitical TimesApril 15th, 2014More people are choosing not to know what’s in their genome and more people are sharing the complexities and challenges of knowing. How can their choices and experiences inform policy?
Guarantee Privacy to Ensure Proper Treatmentby Jeremy GruberThe New York Times, Room for DebateApril 14th, 2014As more and more of this personal information becomes public knowledge, it can be bought and sold by any commercial interests interested in predictive information about an individual's future health status.
Meet your unborn child – before it's even conceived[Quotes CGS's Marcy Darnovsky]by Catherine de LangeNew ScientistApril 9th, 2014A service that creates digital embryos by virtually mixing two people's DNA will allow parents to screen out genetic disorders – and perhaps much more.
Fetal Abnormalities: The Next Minefield in the Abortion Wars?by Amelia Thomson-DeveauxThe American ProspectApril 9th, 2014Conscience clauses are just the beginning—genetic counselors are on a collision course with state-level abortion politics.
Editorial: Genome editing for allNature BiotechnologyApril 8th, 2014CRISPR-Cas is about to transform how we interrogate genetic variants and model disease.
Fearing Punishment for Bad Genesby Kira PeikoffThe New York TimesApril 7th, 2014People are avoiding genetic testing because of a major omission in the 2008 federal law that bars employers and health insurers from seeking the results of the tests.
Startup Offering DNA Screening of 'Hypothetical Babies' Raises Fears Over Designer Children[Quotes CGS's Marcy Darnovsky]by Catherine de LangeThe GuardianApril 5th, 2014Anne Morriss and Lee Silver are about to launch a company called Genepeeks that uses the DNA of sperm donors and recipients to create "virtual babies."
Genetic Inheritance: How Much do you Want to Know?by Stuart JeffriesThe GuardianApril 4th, 2014Scientist Sharon Moalem says we will soon be able to alter our children's lives with genetic manipulation – would you do it if you could?
A Disturbing Trend: Conscience Clauses Threaten Genetic Counselingby Alex SternHuffPostApril 2nd, 2014Genetic counselors are increasingly being officially recognized and licensed, but some states are imposing "conscience clauses" that in practice may conflict with their professional ethics.
Gene of the Week: Entrepreneurship (again)by Pete ShanksBiopolitical TimesApril 2nd, 2014Scientists keep trying, and failing, to find the gene for starting a business.
In Reversal, Genetics Group Says Patients Should Be Allowed to Refuse 'Incidental' Findings by Jennifer Couzin-FrankelScienceApril 1st, 2014Reversing the controversial recommendation they made last year, the American College of Medical Genetics and Genomics now claim that patients should be allowed to “opt out” of learning how their DNA might increase their risk of disease.
Whole-Genome Sequencing as Part of Newborn Screening?by Chris ChipelloMcGillMarch 26th, 2014Ethical, legal and social issues should be weighed before adopting the technology in public programs, researchers argue.
Breast Cancer Genes and Patient Protection in an Era of Personalized Medicineby Karuna JaggarHuffington PostMarch 20th, 2014Genetic testing is often heralded as a cornerstone of personalized medicine, but progress has lagged while persistent medical, ethical and scientific issues abound.
Displaying 200-219 of 737  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760